selected publications
-
Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity.
Nature medicine.
2020
Academic Article
GET IT
Times cited: 122 -
Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir.
The Journal of experimental medicine.
2019
Academic Article
GET IT
Times cited: 95 -
Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption.
Journal of virology.
2019
Academic Article
GET IT
Times cited: 58 -
Relationship between intact HIV-1 proviruses in circulating CD4+ T cells and rebound viruses emerging during treatment interruption.
Proceedings of the National Academy of Sciences of the United States of America.
2018
Academic Article
GET IT
Times cited: 62 -
Combination therapy with anti-HIV-1 antibodies maintains viral suppression.
Nature.
2018
Academic Article
GET IT
Times cited: 412 -
Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117.
The Journal of experimental medicine.
2018
Academic Article
GET IT
Times cited: 93 -
Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo.
Cell.
2017
Academic Article
GET IT
Times cited: 120 -
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption.
Nature.
2016
Academic Article
GET IT
Times cited: 405 -
Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo.
Science (New York, N.Y.).
2016
Academic Article
GET IT
Times cited: 306 -
Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice.
Cell.
2014
Academic Article
GET IT
Times cited: 340 -
Revaccination with 7-valent pneumococcal conjugate vaccine elicits better serologic response than 23-valent pneumococcal polysaccharide vaccine in HIV-infected adult patients who have undergone primary vaccination with 23-valent pneumococcal polysaccharide vaccine in the era of combination antiretroviral therapy.
Vaccine.
2014
Academic Article
GET IT
Times cited: 22